- A Case of Acneiform Eruption Induced by Bevacizumab
-
Han SH, Kim JH, Oh YW, Kim DH, Choi YS, Suh HS
- KMID: 2446926
- Korean J Dermatol.
- 2019 Mar;57(3):159-161.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema
-
Lee YJ, Kim M
- KMID: 2442626
- Korean J Ophthalmol.
- 2019 Apr;33(2):198-199.
- doi: 10.3341/kjo.2018.0079
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter to the Editor: Effect of Intravitreal Bevacizumab Injection on Retinopathy of Prematurity
-
Kim YC
- KMID: 2214430
- J Korean Ophthalmol Soc.
- 2015 Oct;56(10):1650-1650.
- doi: 10.3341/jkos.2015.56.10.1650
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Bevacizumab-associated Ischemic Colitis Proven by Colonoscopy
-
Lee HI, Kim BC, Kim SY, Han KS, Hong CW, Sohn DK, Chang HJ
- KMID: 2410195
- Korean J Med.
- 2017 Jun;92(3):312-315.
- doi: 10.3904/kjm.2017.92.3.312
Bevacizumab is a monoclonal antibody against vascular endothelial growth factor widely used to treat several types of solid tumor. Although bevacizumab has fewer adverse effects than conventional chemotherapy agents, several... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Results After Application of Bevacizumab in Recurrent Pterygium
-
Lee JW, Park YJ, Kim IT, Lee KW
- KMID: 2405163
- J Korean Ophthalmol Soc.
- 2008 Dec;49(12):1901-1909.
PURPOSE: To clinically establish the effectiveness and safety of bevacizumab on recurrent pterygium. METHODS: Twenty patients with recurrent pterygium were given a subconjunctival injection of 0.3 cc bevacizumab, and were evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Bevacizumab and Ranibizumab on the Expression of eNOS in Trabecular Meshwork Cells
-
Kim SE, Kim JW
- KMID: 2338861
- J Korean Ophthalmol Soc.
- 2014 Aug;55(8):1208-1212.
PURPOSE: To compare the effects of bevacizumab and ranibizumab on the expression of eNOS in cultured human trabecular meshwork cells (HTMC). METHODS: Primarily cultured HTMC were exposed to 0.5 mg/mL bevacizumab... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Effects Between Bevacizumab and Mitomycin C on the Survival of Fibroblasts
-
Kim SH, Kim JW
- KMID: 2214300
- J Korean Ophthalmol Soc.
- 2011 Mar;52(3):345-349.
- doi: 10.3341/jkos.2011.52.3.345
PURPOSE: To compare the antiproliferative effects between bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), and mitomycin C in human Tenon's capsule fibroblasts. METHODS: Primarily cultured human Tenon's capsule... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Bevacizumab on Survival and Production of Nitric Oxide in Trabecular Meshwork Cells
-
Kim SH, Kim JW
- KMID: 2212625
- J Korean Ophthalmol Soc.
- 2009 Sep;50(9):1404-1408.
- doi: 10.3341/jkos.2009.50.9.1404
PURPOSE: To investigate the effect of bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), on the survival and production of nitric oxide (NO) in human trabecular meshwork cells... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Subconjunctival Bevacizumab Injection after Primary Pterygium Surgery
-
Suh JS, Choi SK
- KMID: 2216449
- J Korean Ophthalmol Soc.
- 2013 Jan;54(1):53-59.
- doi: 10.3341/jkos.2013.54.1.53
PURPOSE: To evaluate the effect and safety of subconjunctival bevacizumab injection immediately after primary pterygium surgery. METHODS: From October 2010 to June 2011, 54 patients (54 eyes) with primary pterygium who... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Subconjunctival Bevacizumab Injection before Conjunctival Autograft for Pterygium
-
Kim YI, Lee GY, Kim EJ, Kim YH, Lee KW, Park YJ
- KMID: 2339148
- J Korean Ophthalmol Soc.
- 2015 Jun;56(6):847-855.
- doi: 10.3341/jkos.2015.56.6.847
PURPOSE: To evaluate the effect of subconjunctival bevacizumab injection before conjunctival autograft for pterygium. METHODS: Twenty-five eyes (25 patients) with pterygium received a subconjunctival injection of 2.5 mg (0.1 mL) bevacizumab... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Tongue Lymphangioma with Intralesional Combination Injection of Steroid, Bleomycin and Bevacizumab
-
Hwang J, Lee YK, Burm JS
- KMID: 2375224
- Arch Craniofac Surg.
- 2017 Mar;18(1):54-58.
- doi: 10.7181/acfs.2017.18.1.54
Lymphangioma is a congenital malformed lymphatic tumor that rarely involves the tongue. In our clinic, a 10-year-old female presented with lymphangioma circumscriptum involving the right two-thirds of the tongue. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Bevacizumab induced intestinal perforation in patients with colorectal cancer
-
Baek SY, Lee SH, Lee SH
- KMID: 2452894
- Korean J Clin Oncol.
- 2019 Jun;15(1):15-18.
- doi: 10.14216/kjco.190015
PURPOSE: Bevacizumab has been used as a promising drug for metastatic colorectal cancer in combination with chemotherapeutic agents. However, it has a few serious adverse effects, such as intestinal bleeding... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Visual Loss after Intravitreal Bevacizumab Injection in a Patient with Ocular Ischemic Syndrome
-
Kim JW, Yoon IN
- KMID: 2216408
- J Korean Ophthalmol Soc.
- 2012 Dec;53(12):1893-1897.
- doi: 10.3341/jkos.2012.53.12.1893
PURPOSE: To report a patient with ocular ischemic syndrome who suffered from sudden decrease in visual acuity after bevacizumab injection. CASE SUMMARY: A 70-year-old patient visited the Department of Ophthalmology due... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Intravitreal Bevacizumab Alone Injection and Intravitreal Combination Low-Dose Bevacizumab-Triamcinolone Injection or Diabetic Macular Edema
-
Kim BS, Chung IY, Park JM, Han YS
- KMID: 2338853
- J Korean Ophthalmol Soc.
- 2014 Aug;55(8):1155-1161.
PURPOSE: To report the effects and intraocular pressure results of intravitreal bevacizumab alone injection compared with intravitreal low-dose bevacizumab combined with low-dose triamcinolone injection in patients with diabetic macular edema. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Three Cases of Hereditary Hemorrhagic Telangiectasia Treated with Bevacizumab
-
Lee M, Park P, Kim D, Jin HR
- KMID: 2350486
- Korean J Otorhinolaryngol-Head Neck Surg.
- 2016 Aug;59(8):613-619.
- doi: 10.3342/kjorl-hns.2016.59.8.613
Hereditary hemorrhagic telangiectasia (HHT) is a hereditary, autosomal dominant, vascular dysplasia characterized by mucocutaneous telangiectasia, epistaxis, gastrointestinal bleeding, and iron deficiency anemia. Epistaxis in HHT is a recurrent and debilitating... -
- CITED
-
- Close
- SHARE
-
- Close
- The Short-term Effect of Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
-
Kim HS, Lee JH
- KMID: 2213621
- J Korean Ophthalmol Soc.
- 2010 Jun;51(6):860-864.
- doi: 10.3341/jkos.2010.51.6.860
PURPOSE: To determine whether intravitreal bevacizumab is effective for the treatment of central serous chorioretinopathy. METHODS: We retrospectively examined 42 eyes after intravitreal bevacizumab (1.25 mg) injection for central serous chorioretinopathy.... -
- CITED
-
- Close
- SHARE
-
- Close
- Retinal Vascular Caliber Changes in Diabetic Retinopathy after Panretinal Photocoagulation and Additive Bevacizumab Injections
-
Chey JH, Park JM
- KMID: 2290493
- J Korean Ophthalmol Soc.
- 2016 Jun;57(6):917-923.
- doi: 10.3341/jkos.2016.57.6.917
PURPOSE: To evaluate the effect of panretinal photocoagulation and additive intravitreal bevacizumab injections on central retinal vessel diameters and characteristic retinal vascular caliber changes in diabetic retinopathy. METHODS: Changes in central... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Intravitreal Triamcinolone Acetonide and Bevacizumab Injection on Intraocular Pressure
-
Park JS, Ha SW, Park SB
- KMID: 2213979
- J Korean Ophthalmol Soc.
- 2010 Nov;51(11):1491-1498.
- doi: 10.3341/jkos.2010.51.11.1491
PURPOSE: To compare intraocular pressure (IOP) changes after intravitreal triamcinolone acetonide versus bevacizumab injection. METHODS: IOP was measured in 40 patients who received an intravitreal injection of 0.1 ml triamcinolone and... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Bevacizumab and Combined Low-dose Bevacizumab and Triamcinolone in Central Retinal Vein Occlusion
-
Kim BJ, Kim HW, Han YS, Park JM, Chung IY
- KMID: 2213245
- J Korean Ophthalmol Soc.
- 2016 Mar;57(3):438-444.
- doi: 10.3341/jkos.2016.57.3.438
PURPOSE: To report the effects and intraocular pressure (IOP) results of intravitreal injection of bevacizumab alone compared with intravitreal low-dose bevacizumab combined with low-dose triamcinolone injection in patients with central... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Effect of Intravitreal Bevacizumab for CNV Secondary to Age-Related Macular Degeneration
-
Kim YH, Kim ES, Yu SY, Kwak HW
- KMID: 2405168
- J Korean Ophthalmol Soc.
- 2008 Dec;49(12):1935-1940.
PURPOSE: To investigate the long-term therapeutic effect and safety of repeated intravitreal bevacizumab injections for managing choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). METHODS: Clinical data of 14 eyes... -
- CITED
-
- Close
- SHARE
-
- Close
